» Articles » PMID: 38932358

Ferritin Nanoparticle Delivery of the E2 Protein of Classical Swine Fever Virus Completely Protects Pigs from Lethal Challenge

Overview
Date 2024 Jun 27
PMID 38932358
Authors
Affiliations
Soon will be listed here.
Abstract

Classical swine fever (CSF), caused by the classical swine fever virus (CSFV), results in significant economic losses to the swine industry in many countries. Vaccination represents the primary strategy to control CSF and the CSFV E2 protein is known as the major protective antigen. However, the E2 protein expressed or presented by different systems elicits distinct immune responses. In this study, we established a stable CHO cell line to express the E2 protein and delivered it using self-assembled ferritin nanoparticles (NPs). Subsequently, we compared the adaptive immune responses induced by the E2-ferritin NPs and the monomeric E2 protein produced by the CHO cells or a baculovirus expression system. The results revealed that the NP-delivered E2 protein elicited higher titers of neutralizing antibodies than did the monomeric E2 protein in pigs. Importantly, only the NP-delivered E2 protein significantly induced CSFV-specific IFN-γ-secreting cells. Furthermore, all the pigs inoculated with the E2-ferritin NPs were completely protected from a lethal CSFV challenge infection. These findings demonstrate the ability of the E2-ferritin NPs to protect pigs against the lethal CSFV challenge by eliciting robust humoral and cellular immune responses.

Citing Articles

Ferritin Vaccine Platform for Animal and Zoonotic Viruses.

Ahmadivand S, Fux R, Palic D Vaccines (Basel). 2024; 12(10).

PMID: 39460279 PMC: 11511493. DOI: 10.3390/vaccines12101112.


Self-Assembled Ferritin Nanoparticles for Delivery of Antigens and Development of Vaccines: From Structure and Property to Applications.

Cao S, Ma D, Ji S, Zhou M, Zhu S Molecules. 2024; 29(17).

PMID: 39275069 PMC: 11397193. DOI: 10.3390/molecules29174221.

References
1.
Gao F, Jiang Y, Li G, Zhou Y, Yu L, Li L . Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV. Vaccine. 2018; 36(23):3269-3277. DOI: 10.1016/j.vaccine.2018.04.079. View

2.
Reed S, Tomai M, Gale Jr M . New horizons in adjuvants for vaccine development. Curr Opin Immunol. 2020; 65:97-101. PMC: 7542129. DOI: 10.1016/j.coi.2020.08.008. View

3.
Graham S, Everett H, Haines F, Johns H, Sosan O, Salguero F . Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity. PLoS One. 2012; 7(1):e29310. PMC: 3250419. DOI: 10.1371/journal.pone.0029310. View

4.
Dudek N, Perlmutter P, Aguilar M, Croft N, Purcell A . Epitope discovery and their use in peptide based vaccines. Curr Pharm Des. 2010; 16(28):3149-57. DOI: 10.2174/138161210793292447. View

5.
Ganges L, Crooke H, Bohorquez J, Postel A, Sakoda Y, Becher P . Classical swine fever virus: the past, present and future. Virus Res. 2020; 289:198151. DOI: 10.1016/j.virusres.2020.198151. View